Abstract
Bacterial biofilms are highly organized surface-associated communities of bacteria encased within an extracellular matrix produced by themselves, capable of growing in connection with different biological or inert surfaces such as artificial joints or catheters. Biofilms are commonly associated with many health problems, such as endocarditis, otitis media, periodontitis, prostatitis, and urinary tract infections. Several bacteria, such as Escherichia coli, Staphylococcus aureus, Streptococcus mutans, and Pseudomonas aeruginosa, or fungal pathogen as Candida albicans, can form biofilms in the body tissues, leading to different infections. The inherently defensive character of the biofilm is demonstrated by enhanced persistence of bacteria grown in the sessile mode respect to bacteria grown planktonically. This makes most biofilm- associated infections difficult to eradicate, thus contributing to disease chronicity. Since natural products provide a diverse array of chemical structures and possess a wide variety of biological properties, natural resources are worldwide exploited in the search of new pharmaceuticals. In this context bioactive secondary metabolites from natural sources, useful for the new antimicrobial and anti-biofilm drugs, are of interest. In this review, the role of small molecules from plants and marine organisms in inhibiting and/or dispersing bacterial biofilms is discussed, as well as the approaches that have been applied to the discovery of lead small molecules that mediate biofilm development. Molecules inhibiting the formation of biofilm may have therapeutic potential. Several candidates, as halogenated furanones, 2-amminoimidazole alkaloids and flavonoids have been already isolated and characterized from many plants and from marine organisms.
Keywords: Biofilm, Candida albicans, natural compounds, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus mutans.
Mini-Reviews in Medicinal Chemistry
Title:Recent Advances in Natural Product-Based Anti-Biofilm Approaches to Control Infections
Volume: 14 Issue: 14
Author(s): Elisabetta Buommino, Monica Scognamiglio, Giovanna Donnarumma, Antonio Fiorentino and Brigida D’Abrosca
Affiliation:
Keywords: Biofilm, Candida albicans, natural compounds, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus mutans.
Abstract: Bacterial biofilms are highly organized surface-associated communities of bacteria encased within an extracellular matrix produced by themselves, capable of growing in connection with different biological or inert surfaces such as artificial joints or catheters. Biofilms are commonly associated with many health problems, such as endocarditis, otitis media, periodontitis, prostatitis, and urinary tract infections. Several bacteria, such as Escherichia coli, Staphylococcus aureus, Streptococcus mutans, and Pseudomonas aeruginosa, or fungal pathogen as Candida albicans, can form biofilms in the body tissues, leading to different infections. The inherently defensive character of the biofilm is demonstrated by enhanced persistence of bacteria grown in the sessile mode respect to bacteria grown planktonically. This makes most biofilm- associated infections difficult to eradicate, thus contributing to disease chronicity. Since natural products provide a diverse array of chemical structures and possess a wide variety of biological properties, natural resources are worldwide exploited in the search of new pharmaceuticals. In this context bioactive secondary metabolites from natural sources, useful for the new antimicrobial and anti-biofilm drugs, are of interest. In this review, the role of small molecules from plants and marine organisms in inhibiting and/or dispersing bacterial biofilms is discussed, as well as the approaches that have been applied to the discovery of lead small molecules that mediate biofilm development. Molecules inhibiting the formation of biofilm may have therapeutic potential. Several candidates, as halogenated furanones, 2-amminoimidazole alkaloids and flavonoids have been already isolated and characterized from many plants and from marine organisms.
Export Options
About this article
Cite this article as:
Buommino Elisabetta, Scognamiglio Monica, Donnarumma Giovanna, Fiorentino Antonio and D’Abrosca Brigida, Recent Advances in Natural Product-Based Anti-Biofilm Approaches to Control Infections, Mini-Reviews in Medicinal Chemistry 2014; 14 (14) . https://dx.doi.org/10.2174/1389557515666150101095853
DOI https://dx.doi.org/10.2174/1389557515666150101095853 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Torsades de Pointes in Patients with Polymyalgia Rheumatica
Current Pharmaceutical Design Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Occurrence and Clinical Impact of Microembolic Signals (MES) in Patients with Chronic Cardiac Diseases and Atheroaortic Plaques - A Systematic Review
Current Vascular Pharmacology The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology Endocarditis Due to Salmonella Enterica Subsp. Arizonae in a Patient with Sickle Cell Disease: A Case Report and Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Indications for Heart Transplantation in Congenital Heart Disease
Current Cardiology Reviews Biofilms and their Role in the Resistance of Pathogenic Candida to Antifungal Agents
Current Drug Targets DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Biofilms in Skin Infections: Propionibacterium acnes and Acne Vulgaris
Infectious Disorders - Drug Targets Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews Waste Material of Propolis as a Film Forming Agent Intended to Modify the Metronidazole Release: Preparation and Characterization
Current Drug Delivery Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study
Current Rheumatology Reviews Nanomedical Strategies for Targeting Skin Microbiomes
Current Drug Metabolism Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Evolution and Analysis of Heterogeneity in the Clinical Expression of Aortic Diseases Similar to Marfan’s Syndrome: Challenge and Art in Clinical Diagnosis
Current Rheumatology Reviews Antimicrobial Development in the Era of Emerging Resistance
Mini-Reviews in Medicinal Chemistry Helminth Infections and Cardiovascular Diseases: Toxocara Species is Contributing to the Disease
Current Cardiology Reviews Methylene Blue not Contraindicated in Treating Hemodynamic Instability in Pediatric and Neonate Patients
Current Pediatric Reviews Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials